Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
每周口服给药的 DRD2 拮抗剂 ONC201 在晚期实体瘤患者中的安全性和增强的免疫刺激活性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0599-8
Stein, Mark N; Malhotra, Jyoti; Tarapore, Rohinton S; Malhotra, Usha; Silk, Ann W; Chan, Nancy; Rodriguez, Lorna; Aisner, Joseph; Aiken, Robert D; Mayer, Tina; Haffty, Bruce G; Newman, Jenna H; Aspromonte, Salvatore M; Bommareddy, Praveen K; Estupinian, Ricardo; Chesson, Charles B; Sadimin, Evita T; Li, Shengguo; Medina, Daniel J; Saunders, Tracie; Frankel, Melissa; Kareddula, Aparna; Damare, Sherrie; Wesolowsky, Elayne; Gabel, Christian; El-Deiry, Wafik S; Prabhu, Varun V; Allen, Joshua E; Stogniew, Martin; Oster, Wolfgang; Bertino, Joseph R; Libutti, Steven K; Mehnert, Janice M; Zloza, Andrew
